Advertisement
Screener

TRAVERE THERAPEUTICS, INC. (TVTX) Basic Shares Outstanding (Weighted Average)

2.8 / 5 stars · 68/120 Roast Me

TRAVERE THERAPEUTICS, INC. Basic Shares Outstanding (Weighted Average)

TRAVERE THERAPEUTICS, INC. (TVTX) reported Basic Shares Outstanding (Weighted Average) of 93.48 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.

Financial Statements › Income Statement › Earnings Per Share

us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-04

  • TRAVERE THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 93.48M shares, a 5.10% increase year-over-year.
  • TRAVERE THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 91.87M shares, a 3.98% increase year-over-year.
  • TRAVERE THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 90.31M shares, a 8.62% increase year-over-year.
  • TRAVERE THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 89.23M shares, a 14.72% increase year-over-year.
  • TRAVERE THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2025 was 89.21M shares, a 13.09% increase from fiscal 2024.
  • TRAVERE THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2024 was 78.89M shares, a 6.22% increase from fiscal 2023.
  • TRAVERE THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2023 was 74.27M shares, a 16.48% increase from fiscal 2022.
  • TRAVERE THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2022 was 63.76M shares, a 6.56% increase from fiscal 2021.
Period endWeighted Average Number of Shares Outstanding, Basic 3 monthWeighted Average Number of Shares Outstanding, Basic 6 monthWeighted Average Number of Shares Outstanding, Basic 9 monthWeighted Average Number of Shares Outstanding, Basic 12 month
2026-06-3093.48M shares
10-Q · filed 2026-08-04
92.68M shares
10-Q · filed 2026-08-04
91.88M shares
derived: average of 3 quarters · filed 2026-08-04
91.22M shares
derived: average of 4 quarters · filed 2026-08-04
2026-03-3191.87M shares
10-Q · filed 2026-05-04
91.09M shares
derived: average of 2 quarters · filed 2026-05-04
90.47M shares
derived: average of 3 quarters · filed 2026-05-04
90.09M shares
derived: average of 4 quarters · filed 2026-08-04
2025-12-3190.31M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19
89.77M shares
derived: average of 2 quarters · filed 2026-02-19
89.49M shares
derived: average of 3 quarters · filed 2026-08-04
89.21M shares
10-K · filed 2026-02-19
2025-09-3089.23M shares
10-Q · filed 2025-10-30
89.09M shares
derived: average of 2 quarters · filed 2026-08-04
88.85M shares
10-Q · filed 2025-10-30
87.42M shares
derived: average of 4 quarters · filed 2026-08-04
2025-06-3088.95M shares
10-Q · filed 2026-08-04
88.65M shares
10-Q · filed 2026-08-04
86.81M shares
derived: average of 3 quarters · filed 2026-08-04
84.55M shares
derived: average of 4 quarters · filed 2026-08-04
2025-03-3188.36M shares
10-Q · filed 2026-05-04
85.75M shares
derived: average of 2 quarters · filed 2026-05-04
83.09M shares
derived: average of 3 quarters · filed 2026-05-04
81.69M shares
derived: average of 4 quarters · filed 2026-05-04
2024-12-3183.14M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19
80.46M shares
derived: average of 2 quarters · filed 2026-02-19
79.47M shares
derived: average of 3 quarters · filed 2026-02-19
78.89M shares
10-K · filed 2026-02-19
2024-09-3077.78M shares
10-Q · filed 2025-10-30
77.64M shares
derived: average of 2 quarters · filed 2025-10-30
77.47M shares
10-Q · filed 2025-10-30
77.23M shares
derived: average of 4 quarters · filed 2026-02-19
2024-06-3077.50M shares
10-Q · filed 2025-08-06
77.32M shares
10-Q · filed 2025-08-06
77.05M shares
derived: average of 3 quarters · filed 2026-02-19
76.86M shares
derived: average of 4 quarters · filed 2026-02-19
2024-03-3177.14M shares
10-Q · filed 2025-05-01
76.82M shares
derived: average of 2 quarters · filed 2026-02-19
76.65M shares
derived: average of 3 quarters · filed 2026-02-19
76.49M shares
derived: average of 4 quarters · filed 2026-02-19
2023-12-3176.50M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19
76.40M shares
derived: average of 2 quarters · filed 2026-02-19
76.27M shares
derived: average of 3 quarters · filed 2026-02-19
74.27M shares
10-K · filed 2026-02-19
2023-09-3076.31M shares
10-Q · filed 2024-10-31
76.15M shares
derived: average of 2 quarters · filed 2024-10-31
73.52M shares
10-Q · filed 2024-10-31
71.18M shares
derived: average of 4 quarters · filed 2025-02-21
2023-06-3076.00M shares
10-Q · filed 2024-08-01
72.11M shares
10-Q · filed 2024-08-01
69.47M shares
derived: average of 3 quarters · filed 2025-02-21
68.11M shares
derived: average of 4 quarters · filed 2025-02-21
2023-03-3168.17M shares
10-Q · filed 2024-05-06
66.20M shares
derived: average of 2 quarters · filed 2025-02-21
65.48M shares
derived: average of 3 quarters · filed 2025-02-21
65.02M shares
derived: average of 4 quarters · filed 2025-02-21
2022-12-3164.22M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-21
64.13M shares
derived: average of 2 quarters · filed 2025-02-21
63.96M shares
derived: average of 3 quarters · filed 2025-02-21
63.76M shares
10-K · filed 2025-02-21
2022-09-3064.03M shares
10-Q · filed 2023-11-07
63.84M shares
derived: average of 2 quarters · filed 2023-11-07
63.60M shares
10-Q · filed 2023-11-07
63.11M shares
derived: average of 4 quarters · filed 2024-02-20
2022-06-3063.64M shares
10-Q · filed 2023-08-03
63.39M shares
10-Q · filed 2023-08-03
62.80M shares
derived: average of 3 quarters · filed 2024-02-20
62.30M shares
derived: average of 4 quarters · filed 2024-02-20
2022-03-3163.13M shares
10-Q · filed 2023-05-04
62.38M shares
derived: average of 2 quarters · filed 2024-02-20
61.86M shares
derived: average of 3 quarters · filed 2024-02-20
61.54M shares
derived: average of 4 quarters · filed 2024-02-20
2021-12-3161.64M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20
61.22M shares
derived: average of 2 quarters · filed 2024-02-20
61.00M shares
derived: average of 3 quarters · filed 2024-02-20
59.83M shares
10-K · filed 2024-02-20
2021-09-3060.80M shares
10-Q · filed 2022-10-27
60.69M shares
derived: average of 2 quarters · filed 2022-10-27
59.23M shares
10-Q · filed 2022-10-27
57.23M shares
derived: average of 4 quarters · filed 2023-02-23
2021-06-3060.57M shares
10-Q · filed 2022-08-04
58.43M shares
10-Q · filed 2022-08-04
56.04M shares
derived: average of 3 quarters · filed 2023-02-23
54.77M shares
derived: average of 4 quarters · filed 2023-02-23
2021-03-3156.27M shares
10-Q · filed 2022-05-05
53.78M shares
derived: average of 2 quarters · filed 2023-02-23
52.83M shares
derived: average of 3 quarters · filed 2023-02-23
50.81M shares
derived: average of 4 quarters · filed 2023-02-23
2020-12-3151.29M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23
51.11M shares
derived: average of 2 quarters · filed 2023-02-23
48.99M shares
derived: average of 3 quarters · filed 2023-02-23
47.54M shares
10-K · filed 2023-02-23
2020-09-3050.93M shares
10-Q · filed 2021-10-29
47.85M shares
derived: average of 2 quarters · filed 2021-10-29
46.29M shares
10-Q · filed 2021-10-29
2020-06-3044.76M shares
10-Q · filed 2021-07-29
43.94M shares
10-Q · filed 2021-07-29
2020-03-3143.12M shares
10-Q · filed 2021-05-06
2019-12-3142.34M shares
10-K · filed 2022-02-24
2019-03-3141.41M shares
10-Q · filed 2020-05-11
2018-12-3140.43M shares
10-K · filed 2019-02-26
2018-03-3139.66M shares
10-Q · filed 2018-07-06
39.92M shares
derived: average of 2 quarters · filed 2019-02-26
39.50M shares
derived: average of 3 quarters · filed 2019-02-26
39.38M shares
derived: average of 4 quarters · filed 2019-02-26
2017-12-3140.17M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26
39.41M shares
derived: average of 2 quarters · filed 2019-02-26
39.29M shares
derived: average of 3 quarters · filed 2019-02-26
38.77M shares
10-K · filed 2019-02-26
2017-09-3038.65M shares
10-Q · filed 2017-11-07
38.85M shares
derived: average of 2 quarters · filed 2017-11-07
38.30M shares
10-Q · filed 2017-11-07
38.39M shares
derived: average of 4 quarters · filed 2019-02-26
2017-06-3039.04M shares
10-Q · filed 2017-08-09
38.55M shares
10-Q · filed 2017-08-09
38.30M shares
derived: average of 3 quarters · filed 2019-02-26
37.97M shares
derived: average of 4 quarters · filed 2019-02-26
2017-03-3138.05M shares
10-Q · filed 2018-07-06
37.93M shares
derived: average of 2 quarters · filed 2019-02-26
37.61M shares
derived: average of 3 quarters · filed 2019-02-26
37.38M shares
derived: average of 4 quarters · filed 2019-02-26
2016-12-3137.80M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26
37.39M shares
derived: average of 2 quarters · filed 2019-02-26
37.16M shares
derived: average of 3 quarters · filed 2019-02-26
37.00M shares
10-K · filed 2019-02-26
2016-09-3036.98M shares
10-Q · filed 2017-11-07
36.83M shares
derived: average of 2 quarters · filed 2017-11-07
36.73M shares
10-Q · filed 2017-11-07
36.62M shares
derived: average of 4 quarters · filed 2018-07-06
2016-06-3036.68M shares
10-Q · filed 2017-08-09
36.60M shares
10-Q · filed 2017-08-09
36.50M shares
derived: average of 3 quarters · filed 2018-07-06
36.31M shares
derived: average of 4 quarters · filed 2018-07-06
2016-03-3136.52M shares
10-Q · filed 2017-05-05
36.40M shares
derived: average of 2 quarters · filed 2018-07-06
36.18M shares
derived: average of 3 quarters · filed 2018-07-06
35.88M shares
derived: average of 4 quarters · filed 2018-07-06
2015-12-3136.29M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2018-07-06
36.02M shares
derived: average of 2 quarters · filed 2018-07-06
35.66M shares
derived: average of 3 quarters · filed 2018-07-06
33.56M shares
10-K · filed 2018-07-06
2015-09-3035.74M shares
10-Q · filed 2016-11-04
35.35M shares
derived: average of 2 quarters · filed 2016-11-04
32.65M shares
10-Q · filed 2016-11-04
30.60M shares
derived: average of 4 quarters · filed 2017-03-01
2015-06-3034.96M shares
10-Q · filed 2016-08-05
31.08M shares
10-Q · filed 2016-08-05
28.89M shares
derived: average of 3 quarters · filed 2017-03-01
28.33M shares
derived: average of 4 quarters · filed 2017-03-01
2015-03-3127.16M shares
10-Q · filed 2016-05-05
25.85M shares
derived: average of 2 quarters · filed 2017-03-01
26.13M shares
derived: average of 3 quarters · filed 2017-03-01
26.00M shares
derived: average of 4 quarters · filed 2017-03-01
2014-12-3124.54M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01
25.61M shares
derived: average of 2 quarters · filed 2017-03-01
25.62M shares
derived: average of 3 quarters · filed 2017-03-01
25.06M shares
10-K · filed 2017-03-01
2014-09-3026.68M shares
10-Q · filed 2015-11-06
26.16M shares
derived: average of 2 quarters · filed 2015-11-06
25.23M shares
10-Q · filed 2015-11-06
23.52M shares
derived: average of 4 quarters · filed 2016-02-26
2014-06-3025.64M shares
10-Q · filed 2015-08-10
24.49M shares
10-Q · filed 2015-08-10
22.47M shares
derived: average of 3 quarters · filed 2016-02-26
20.69M shares
derived: average of 4 quarters · filed 2016-02-26
2014-03-3123.33M shares
10-Q · filed 2015-05-11
20.88M shares
derived: average of 2 quarters · filed 2016-02-26
19.04M shares
derived: average of 3 quarters · filed 2016-02-26
17.35M shares
derived: average of 4 quarters · filed 2016-02-26
2013-12-3118.43M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26
16.90M shares
derived: average of 2 quarters · filed 2016-02-26
15.35M shares
derived: average of 3 quarters · filed 2016-02-26
14.21M shares
10-K · filed 2016-02-26
2013-09-3015.37M shares
10-Q · filed 2014-11-13
13.81M shares
derived: average of 2 quarters · filed 2014-11-13
12.80M shares
10-Q · filed 2014-11-13
2013-06-3012.25M shares
10-Q · filed 2014-08-14
11.49M shares
10-Q · filed 2014-08-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
Oruka Therapeutics, Inc. (ORKA)United States$5.663B-43.76
Mirum Pharmaceuticals, Inc. (MIRM)United States$5.798B-8.81
Cogent Biosciences, Inc. (COGT)United States$5.450B-17.61
Gossamer Bio, Inc. (GOSS)United States$5.355B-0.65
PTC THERAPEUTICS, INC. (PTCT)United States$5.199B-177.07
Amneal Pharmaceuticals, Inc. (AMRX)$6.326B25.62
Dianthus Therapeutics, Inc. /DE/ (DNTH)United States$5.082B-27.79
Liquidia Corp (LQDA)United States$6.347B51.23
Erasca, Inc. (ERAS)United States$5.073B-19.96
Veradermics, Inc (MANE)United States$4.839B